Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs.
暂无分享,去创建一个
K. Sasahara | T. Nitanai | T. Habara | T. Kojima | Y. Kawahara | T. Morioka | E. Nakajima
暂无分享,去创建一个
K. Sasahara | T. Nitanai | T. Habara | T. Kojima | Y. Kawahara | T. Morioka | E. Nakajima